Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01124799
What this trial is testing

TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun Light

Who this might be right for
Hepatitis C Virus
Tibotec Pharmaceuticals, Ireland 49
Not applicableUnknownNCT05401136
What this trial is testing

Evaluating the Chain of Addiction Care (CAC)

Who this might be right for
Hepatitis C, ChronicSubstance Use Disorders
Radboud University Medical Center 1,000
Large-scale testing (Phase 3)Study completedNCT00538811
What this trial is testing

Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders

Who this might be right for
Hepatitis CGenotype 3Non-responders+1 more
Aga Khan University 40
Testing effectiveness (Phase 2)Study completedNCT01974687
What this trial is testing

Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 178
Early research (Phase 1)Study completedNCT02063607
What this trial is testing

The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 60
Not applicableStudy completedNCT00007371
What this trial is testing

Hepatitis C in Clinically Discordant Hemophilic Siblings

Who this might be right for
Blood DiseaseHemophilia AHepatitis, Viral, Human
University of North Carolina, Chapel Hill
Early research (Phase 1)Study completedNCT00688012
What this trial is testing

Safety Study of SPC3649 in Healthy Men

Who this might be right for
Hepatitis C
Santaris Pharma A/S 64
Not applicableLooking for participantsNCT06718530
What this trial is testing

Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development

Who this might be right for
Hepatitis C Virus Infection
Centro di Riferimento Oncologico - Aviano 1,000
Large-scale testing (Phase 3)Study completedNCT00161928
What this trial is testing

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Who this might be right for
Meningitis, Meningococcal
Pfizer 330
Early research (Phase 1)Study completedNCT00752544
What this trial is testing

TMC435350-TiDP16-C109: A Safety Study for TMC435350 in an Oral Solution Containing Either 100, 200 or 400 mg Equivalent of TMC435350 or Placebo in Healthy Japanese Male Volunteers

Who this might be right for
HCV
Tibotec Pharmaceuticals, Ireland 30
Large-scale testing (Phase 3)Study completedNCT02442271
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 222
Not applicableStudy completedNCT02505243
What this trial is testing

Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens

Who this might be right for
HCV CoinfectionHepatitis C
Radboud University Medical Center 252
Not applicableStudy completedNCT05270135
What this trial is testing

ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs

Who this might be right for
Skin and Soft Tissue InfectionsHivHepatitis C+1 more
University of Arizona 18
Testing effectiveness (Phase 2)Study completedNCT00561015
What this trial is testing

A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 52
Testing effectiveness (Phase 2)Study completedNCT02583685
What this trial is testing

Switching Regimen in Treating Cirrhotic HCV GT1b Subjects

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 138
Post-approval studies (Phase 4)Study completedNCT03133065
What this trial is testing

Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAs

Who this might be right for
Liver Transplantation
Ain Shams University 89
Testing effectiveness (Phase 2)Study completedNCT02118012
What this trial is testing

Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Not applicableStudy completedNCT03740230
What this trial is testing

An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs

Who this might be right for
Hepatitis C
AbbVie 3,134
Large-scale testing (Phase 3)Study completedNCT02707601
What this trial is testing

Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment

Who this might be right for
HIV-1 InfectionHCV Infection
Gilead Sciences 150
Not applicableStudy completedNCT01050881
What this trial is testing

Notification of Donors With Positive Microbiology Markers

Who this might be right for
Human Immunodeficiency VirusHepatitis BHepatitis C+2 more
NHS Blood and Transplant 217
Next Page